Reuters logo
BRIEF-Cadila Healthcare's Zydus gets final FDA nod for hep B drug
June 27, 2017 / 4:36 AM / 3 months ago

BRIEF-Cadila Healthcare's Zydus gets final FDA nod for hep B drug

June 27 (Reuters) - Cadila Healthcare Ltd:

* Says Zydus receives final approval from the USFDA for entecavir tablets

* Says drug used for treatment of hepatitis B virus

* Says drug to be produced at group's formulations manufacturing facility at pharma SEZ in Ahmedabad Source text: bit.ly/2sbzQRU Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below